Your browser doesn't support javascript.
loading
Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations.
Ruiz-Cordero, Roberto; Ma, Junsheng; Khanna, Abha; Lyons, Genevieve; Rinsurongkawong, Waree; Bassett, Roland; Guo, Ming; Routbort, Mark J; Zhang, Jianjun; Skoulidis, Ferdinandos; Heymach, John; Roarty, Emily B; Tang, Zhenya; Medeiros, L Jeffrey; Patel, Keyur P; Luthra, Rajyalakshmi; Roy-Chowdhuri, Sinchita.
Afiliación
  • Ruiz-Cordero R; Department of Pathology, University of California San Francisco, 1825 4th Street, Room L2181A, San Francisco, CA, 94158, USA. Roberto.Ruiz-Cordero@ucsf.edu.
  • Ma J; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Khanna A; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lyons G; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rinsurongkawong W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bassett R; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Guo M; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Routbort MJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Skoulidis F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Heymach J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Roarty EB; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tang Z; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Medeiros LJ; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Patel KP; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Luthra R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Roy-Chowdhuri S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
BMC Cancer ; 20(1): 83, 2020 Jan 31.
Article en En | MEDLINE | ID: mdl-32005111
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Proteínas Proto-Oncogénicas p21(ras) / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteína p53 Supresora de Tumor / Proteínas Proto-Oncogénicas p21(ras) / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos